Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virchows Archiv
Published in: Virchows Archiv 4/2021

01-10-2021 | Crohn's Disease | Original Article

Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn’s disease-associated small bowel carcinoma

Authors: Giovanni Arpa, Alessandro Vanoli, Federica Grillo, Roberto Fiocca, Catherine Klersy, Daniela Furlan, Fausto Sessa, Sandro Ardizzone, Gianluca Sampietro, Maria Cristina Macciomei, Gabriella Nesi, Francesco Tonelli, Carlo Capella, Giovanni Latella, Antonio Ciardi, Roberto Caronna, Marco Vincenzo Lenti, Rachele Ciccocioppo, Valeria Barresi, Deborah Malvi, Antonietta D’Errico, Fernando Rizzello, Gilberto Poggioli, Claudia Mescoli, Massimo Rugge, Ombretta Luinetti, Marco Paulli, Antonio Di Sabatino, Enrico Solcia

Published in: Virchows Archiv | Issue 4/2021

Login to get access

Abstract

Most Crohn’s disease-associated small bowel carcinomas (CrD-SBCs) are diagnosed in advanced stage and have poor prognosis. To improve diagnosis and therapy, a better knowledge of tumour precancerous lesions, histotypes and prognostic factors is needed. We investigated histologically and immunohistochemically 52 CrD-SBCs and 51 small bowel carcinomas unrelated to inflammatory disease, together with their tumour-associated mucosa, looking for Crohn-selective changes. Histologic patterns and phenotypic markers potentially predictive of CrD-SBC histogenesis and prognosis were analysed. Cytokeratin 7 or MUC5AC-positive metaplastic changes were found in about half of investigated CrD-SBCs, significantly more frequently than in CrD-unrelated SBCs. They correlated with metaplastic changes of their associated mucosa, while being absent in normal ileal mucosa. Histologic patterns suggestive for progression of some cytokeratin 7 and/or MUC5AC-positive metaplastic lesions into cancer of the same phenotype were also observed. Patient survival analyses showed that tumour cytokeratin 7 or MUC5AC expression and non-cohesive histotype were adverse prognostic factors at univariable analysis, while cytokeratin 7 and non-cohesive histotype were also found to predict worse survival in stage- and age-inclusive multivariable analyses. Besides conventional dysplasia, hyperplasia-like non-conventional lesions were observed in CrD-SBC-associated mucosa, with patterns suggestive for a histogenetic link with adjacent cancer. In conclusion the cytokeratin 7 and/or MUC5AC-positive metaplastic foci and the non-conventional growths may have a role in cancer histogenesis, while tumour cytokeratin 7 and non-cohesive histotype may also predict poor patient survival. Present findings are worth being considered in future prospective histogenetic and clinical studies.
Appendix
Available only for authorised users
Literature
1.
Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR (1999) Intestinal adenocarcinoma in Crohn’s disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 23:651–655PubMedCrossRef
2.
Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, el-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Fléjou JF, Carbonnel F (2014) Small bowel adenocarcinomas complicating Crohn’s disease are associated with dysplasia: a pathological and molecular study. Inflamm Bowel Dis 20:1584–1592PubMedCrossRef
3.
Vanoli A, Di Sabatino A, Furlan D et al (2017) Small bowel carcinomas in coeliac or Crohn’s disease: clinico-pathological, molecular, and prognostic features. A Study From the Small Bowel Cancer Italian Consortium. J Crohns Colitis 11:942–953PubMedCrossRef
4.
Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, hren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931–968PubMedCrossRef
5.
Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126:1634–1648PubMedCrossRef
6.
Simon M, Cosnes J, Gornet JM, GETAID group et al (2017) Endoscopic detection of small bowel dysplasia and adenocarcinoma in Crohn’s disease: a prospective cohort-study in high-risk patients. J Crohns Colitis 11:47–52PubMedCrossRef
7.
Grolleau C, Pote NM, Guedj NS, Zappa M, Theou-Anton N, Bouhnik Y, Panis Y, Cazals-Hatem DL (2017) Small bowel adenocarcinoma complicating Crohn’s disease: a single-centre experience emphasizing the importance of screening for dysplasia. Virchows Arch 471:611–617PubMedCrossRef
8.
Galandiuk S, Rodriguez-Justo M, Jeffery R et al (2012) Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology 142:855–864PubMedCrossRef
9.
Hirsch D, Wangsa D, Zhu YJ, Hu Y, Edelman DC, Meltzer PS, Heselmeyer-Haddad K, Ott C, Kienle P, Galata C, Horisberger K, Ried T, Gaiser T (2018) Dynamics of genome alterations in Crohn’s disease-associated colorectal carcinogenesis. Clin Cancer Res 24:4997–5011PubMedPubMedCentralCrossRef
10.
Roberts IS, Stoddart RW (1993) Ulcer-associated cell lineage (‘pyloric metaplasia’) in Crohn’s disease: a lectin histochemical study. J Pathol 171:13–19PubMedCrossRef
11.
Whitcomb E, Liu X, Xiao SY (2014) Crohn enteritis-associated small bowel adenocarcinomas exhibit gastric differentiation. Hum Pathol 45:359–367PubMedCrossRef
12.
Kilgore SP, Sigel JE, Goldblum JR (2000) Hyperplastic-like mucosal change in Crohn’s disease: an unusual form of dysplasia? Mod Pathol 13:797–801PubMedCrossRef
13.
Kaneko Y, Nakamura T, Hayama M, Hosaka N, Akamatsu T, Ota H (2008) Altered expression of CDX-2, PDX-1 and mucin core proteins in “Ulcer-associated cell lineage (UACL)” in Crohn’s disease. J Mol Histol 39:161–168PubMedCrossRef
14.
Thorsvik S, Bakke I, van Beelen GA et al (2018) Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn’s disease. Cell Tissue Res 374:339–348PubMedPubMedCentralCrossRef
15.
Vanoli A, Di Sabatino A, Martino M et al (2017) Small bowel carcinomas in celiac or Crohn’s disease: distinctive histophenotypic, molecular and histogenetic patterns. Mod Pathol 30:1453–1466PubMedCrossRef
16.
Kushima R, Borchard F, Hattori T (1997) A new aspect of gastric metaplasia in Crohn’s disease: bidirectional (foveolar and pyloric) differentiation in so-called ‘pyloric metaplasia’ in the ileum. Pathol Int 47:416–419PubMedCrossRef
17.
Jun SY, Eom DW, Park H, Bae YK, Jang KT, Yu E, Hong SM (2014) Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Mod Pathol 27:1364–1374PubMedCrossRef
18.
Stenling R, Lindberg J, Rutegård J et al (2007) Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis. APMIS 115:1219–1226PubMedCrossRef
19.
Choi WT, Yozu M, Miller GC, Shih AR, Kumarasinghe P, Misdraji J, Harpaz N, Lauwers GY (2020) Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study. Mod Pathol 33:933–943PubMedCrossRef
20.
Coit DG, Kelsen D, Tang LH, Erasmus JJ, Gerdes H, Hofstetter WL (2017) Small intestine. In: Amin MB, Edge SB, Greene FL (eds) AJCC Cancer Staging Manual, 8th edn. Springer, New York, pp 221–234CrossRef
21.
Arpa G, Grillo F, Giuffrida P, Nesi G, Klersy C, Mescoli C, Lenti MV, Lobascio G, Martino M, Latella G, Malvi D, Macciomei MC, Fociani P, Villanacci V, Rizzo A, Ferrero S, Sessa F, Orlandi A, Monteleone G, Biancone L, Cantoro L, Tonelli F, Ciardi A, Poggioli G, Rizzello F, Ardizzone S, Sampietro G, Solina G, Oreggia B, Papi C, D’Incà R, Vecchi M, Caprioli F, Caronna R, D’Errico A, Fiocca R, Rugge M, Corazza GR, Luinetti O, Paulli M, Solcia E, di Sabatino A, Vanoli A (2020) Separation of low- versus high-grade Crohn’s disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis. J Crohns Colitis 14:295–302PubMedCrossRef
22.
Vanoli A, Grillo F, Guerini C, Neri G, Arpa G, Klersy C, Nesi G, Giuffrida P, Sampietro G, Ardizzone S, Fociani P, Fiocca R, Latella G, Sessa F, D’Errico A, Malvi D, Mescoli C, Rugge M, Ferrero S, Poggioli G, Rizzello F, Macciomei MC, Santini D, Volta U, de Giorgio R, Caio G, Calabrò A, Ciacci C, D’Armiento M, Rizzo A, Solina G, Martino M, Tonelli F, Villanacci V, Cannizzaro R, Canzonieri V, Florena AM, Biancone L, Monteleone G, Caronna R, Ciardi A, Elli L, Caprioli F, Vecchi M, D’Incà R, Zingone F, D’Odorico A, Lenti MV, Oreggia B, Reggiani Bonetti L, Giannone AG, Orlandi A, Barresi V, Ciccocioppo R, Amodeo G, Biletta E, Luinetti O, Pedrazzoli P, Pietrabissa A, Corazza GR, Solcia E, Paulli M, di Sabatino A (2021) Prognostic role of mismatch repair status, histotype and high-risk pathologic features in stage II small bowel adenocarcinomas. Ann Surg Oncol 28:1167–1177PubMedCrossRef
23.
Rizzo F, Vanoli A, Sahnane N, Cerutti R, Trapani D, Rinaldi A, Sellitto A, Ciacci C, Volta U, Villanacci V, Calabrò A, Arpa G, Luinetti O, Paulli M, Solcia E, di Sabatino A, Sessa F, Weisz A, Furlan D (2020) Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes. Virchows Arch 476:711–723PubMedCrossRef
24.
Chiaravalli AM, Feltri M, Bertolini V, Bagnoli E, Furlan D, Cerutti R, Novario R, Capella C (2006) Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch 448:344–353PubMedCrossRef
25.
Nearchou IP, Kajiwara Y, Mochizuki S, Harrison DJ, Caie PD, Ueno H (2019) Novel internationally verified method reports desmoplastic reaction as the most significant prognostic feature for disease-specific survival in stage II colorectal cancer. Am J Surg Pathol 43:1239–1248PubMedCrossRef
26.
Chen ZM, Wang HL (2004) Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol 28:1352–1359PubMedCrossRef
27.
Kaserer K, Schmaus J, Bethge U, Migschitz B, Fasching S, Walch A, Herbst F, Teleky B, Wrba F (2000) Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 190:450–456PubMedCrossRef
28.
Ueno H, Murphy J, Jass JR et al (2000) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132CrossRef
29.
Barresi V, Reggiani Bonetti L, Ieni A, Caruso RA, Tuccari G (2017) Poorly differentiated clusters: clinical impact in colorectal cancer. Clin Colorectal Cancer 16:9–15PubMedCrossRef
30.
Andersen SN, Lovig T, Clausen OP et al (1999) Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut 45:686–692PubMedPubMedCentralCrossRef
31.
Shibahara H, Higashi M, Koriyama C, Yokoyama S, Kitazono I, Kurumiya Y, Narita M, Kuze S, Kyokane T, Mita S, Arai T, Kato T, Yuasa N, Yamaguchi R, Kubota H, Suzuki H, Baba S, Rousseau K, Batra SK, Yonezawa S (2014) Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. PLoS One 9:e86111PubMedPubMedCentralCrossRef
32.
Xue Y, Reid MD, Balci S et al (2011) Immunohistochemical classification of ampullary carcinomas: critical reappraisal fails to confirm prognostic relevance for recently proposed panels, and highlights MUC5AC as a strong prognosticator. Am J Surg Pathol 41:865–876CrossRef
33.
Ushiku T, Arnason T, Fukayama M, Lauwers GY (2014) Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 38:1484–1493PubMedCrossRef
34.
Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, Langner C (2011) Keratin 7 expression in colorectal cancer--freak of nature or significant finding? Histopathology 59:225–234PubMedCrossRef
35.
Fei F, Li C, Cao Y, Liu K, du J, Gu Y, Wang X, Li Y, Zhang S (2019) CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes’ stage of primary colorectal cancers. J Cancer 10:2510–2519PubMedPubMedCentralCrossRef
36.
Wu Y, Grabsch H, Ivanova T, Tan IB, Murray J, Ooi CH, Wright AI, West NP, Hutchins GGA, Wu J, Lee M, Lee J, Koo JH, Yeoh KG, van Grieken N, Ylstra B, Rha SY, Ajani JA, Cheong JH, Noh SH, Lim KH, Boussioutas A, Lee JS, Tan P (2013) Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut 62:1100–1111PubMedCrossRef
37.
Wang LM, Silva MA, D'Costa Z et al (2016) The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget 7:4183–4194PubMedCrossRef
38.
Kim A, Bae YK, Gu MJ et al (2013) Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma. Pathology 45:567–573PubMedCrossRef
39.
Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, Inghirami G, Trusolino L, Fekete Z, de Ridder M, Cassoni P, Storme G, Bertotti A, Medico E (2015) Stromal contribution to the colorectal cancer transcriptome. Nat Genet 47:312–319PubMedCrossRef
40.
Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, de Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350–1356PubMedPubMedCentralCrossRef
41.
Solcia E, Klersy C, Vanoli A, Grillo F, Manca R, Tava F, Luinetti O, Fiocca R (2013) The contribution of cell phenotype to the behavior of gastric cancer. Gastric Cancer 16:462–471PubMedCrossRef
42.
Giuffrida P, Arpa G, Grillo F, Klersy C, Sampietro G, Ardizzone S, Fociani P, Fiocca R, Latella G, Sessa F, D’Errico A, Malvi D, Mescoli C, Rugge M, Nesi G, Ferrero S, Furlan D, Poggioli G, Rizzello F, Macciomei MC, Santini D, Volta U, de Giorgio R, Caio G, Calabrò A, Ciacci C, D’Armiento M, Rizzo A, Solina G, Martino M, Tonelli F, Villanacci V, Cannizzaro R, Canzonieri V, Florena AM, Biancone L, Monteleone G, Caronna R, Ciardi A, Elli L, Caprioli F, Vecchi M, D’Incà R, Zingone F, D’Odorico A, Lenti MV, Oreggia B, Reggiani Bonetti L, Astegiano M, Biletta E, Cantoro L, Giannone AG, Orlandi A, Papi C, Perfetti V, Quaquarini E, Sandri G, Silano M, Usai P, Barresi V, Ciccocioppo R, Luinetti O, Pedrazzoli P, Pietrabissa A, Viglio A, Paulli M, Corazza GR, Solcia E, Vanoli A, di Sabatino A (2020) PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Mod Pathol 33:1398–1409PubMedCrossRef
43.
Simmini S, Bialecka M, Huch M, Kester L, van de Wetering M, Sato T, Beck F, van Oudenaarden A, Clevers H, Deschamps J (2014) Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2. Nat Commun 5:5728PubMedCrossRef
44.
Kirchner T, Müller S, Hattori T, Mukaisyo K, Papadopoulos T, Brabletz T, Jung A (2001) Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch 439:512–522PubMedCrossRef
45.
Kojima J, Fukuda A, Taira H, Kawasaki T, Ito H, Kuji N, Isaka K, Umezawa A, Akutsu H (2017) Efficient production of trophoblast lineage cells from human induced pluripotent stem cells. Lab Investig 97:1188–1200PubMedCrossRef
46.
Tajima Y, Ito K, Umino A, Wilkinson AC, Nakauchi H, Yamazaki S (2017) Continuous cell supply from Krt7-expressing hematopoietic stem cells during native hematopoiesis revealed by targeted in vivo gene transfer method. Sci Rep 7:40684PubMedPubMedCentralCrossRef
47.
Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett’s esophagus from intestinal metaplasia of the stomach. Hum Pathol 30:288–294PubMedCrossRef
48.
Jiang M, Li H, Zhang Y, Yang Y, Lu R, Liu K, Lin S, Lan X, Wang H, Wu H, Zhu J, Zhou Z, Xu J, Lee DK, Zhang L, Lee YC, Yuan J, Abrams JA, Wang TC, Sepulveda AR, Wu Q, Chen H, Sun X, She J, Chen X, Que J (2017) Transitional basal cells at the squamous-columnar junction generate Barrett’s oesophagus. Nature 550:529–533PubMedPubMedCentralCrossRef
49.
Gui X, Köbel M, Ferraz JG et al (2020) Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases. J Clin Pathol 73:391–402PubMedCrossRef
50.
Gui X, Iacucci M, Ghosh S, Ferraz JGP, Lee S (2020) Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era. Hum Pathol 100:24–37PubMedCrossRef
51.
Liao X, Li G, McBride R, Houldsworth J, Harpaz N, Polydorides AD (2020) Clinicopathological and molecular characterisation of Crohn’s disease-associated small bowel adenocarcinomas. J Crohns Colitis 14:287–294PubMedCrossRef
Metadata
Title
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn’s disease-associated small bowel carcinoma
Authors
Giovanni Arpa
Alessandro Vanoli
Federica Grillo
Roberto Fiocca
Catherine Klersy
Daniela Furlan
Fausto Sessa
Sandro Ardizzone
Gianluca Sampietro
Maria Cristina Macciomei
Gabriella Nesi
Francesco Tonelli
Carlo Capella
Giovanni Latella
Antonio Ciardi
Roberto Caronna
Marco Vincenzo Lenti
Rachele Ciccocioppo
Valeria Barresi
Deborah Malvi
Antonietta D’Errico
Fernando Rizzello
Gilberto Poggioli
Claudia Mescoli
Massimo Rugge
Ombretta Luinetti
Marco Paulli
Antonio Di Sabatino
Enrico Solcia
Publication date
01-10-2021
Publisher
Springer Berlin Heidelberg
Keyword
Crohn's Disease
Published in
Virchows Archiv / Issue 4/2021
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-021-03109-2

Other articles of this Issue 4/2021

Virchows Archiv 4/2021 Go to the issue

Correction

Correction to: 33rd European Congress of Pathology – Abstracts

Correction

Correction to: Keratin 7 expression in hepatic cholestatic diseases

Original Article

Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts

Original Article

Cytoplasmic DDX3 as prognosticator in male breast cancer

News

In this issue

Letter to the Editor

Morphological and molecular heterogeneity in testicular germ cell tumors: implications for dedicated investigations